Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • jmartin
    Member
    • Dec 2009
    • 78

    MetaBat2 contig binning question

    I have a collection of metagenomic samples and I want to look at genomic microdiversity between these samples using the 'inStrain' tool. To do that I need to build a genomes db, and the documentation recommends to do de novo MGS assemblies using data from my samples to ensure that my genomes db has the specific genomes that exist in my samples (as opposed to just the closest genomes found in the public repositories).

    So I've assembled each sample (using metaSPAdes & MEGAHIT), merged the resulting contigs into a single db and mapped each of my sample's reads against that db, and then I fed these many bamfiles to MetaBat2, which produced ~8k genome bins, which seems reasonable for my data.

    But I'm now having a problem understanding how this should work. And its probably just my own lack of understanding of contig binning that I am hoping people here can help me with. I feel like each of my genome bins generated by MetaBat2 may have overlapping contig data. It makes sense to me that the contigs are correctly binned by genome, using the depth information per sample and similarity. But from what I've read I don't see anywhere that says each genome bin has been 'flattened' down to just the consensus of the assembly contigs.

    So my question is: After doing contig binning using MetaBat2, do I need to build a single consensus per genome bin? Or has that already been done? Or do people even worry about having overlapping contigs in these genome bins?

Latest Articles

Collapse

  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM
  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    07-08-2026, 05:17 AM
  • GATTACAT
    Reply to Nine Things a Sample Prep Scientist Thinks About Before Sequencing
    by GATTACAT
    Love this - good data definitely starts from good input, and poor input can only give relatively poor data. I particularly like the mention of Nanodrop/absorbance based methods for quantification. It's such a toss up if you'll get an accurate reading or what amounts to a randomly generated number, and a lot of library/sequencing related issues can be traced back to poor quant.
    07-01-2026, 11:43 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 10:26 AM
0 responses
13 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-09-2026, 10:04 AM
0 responses
26 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-08-2026, 10:08 AM
0 responses
16 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-07-2026, 11:05 AM
0 responses
33 views
0 reactions
Last Post SEQadmin2  
Working...